September 9, 2021

The Food Allergy Collaborative is currently preparing for a Externally-led Patient-Focused Drug Development (PFDD) meeting in September, 2021, which will provide a platform for food allergic patients to inform the FDA in understanding of the therapeutic context for drug development and evaluation in food allergy.

I am raw html block.
Click edit button to change this html